Our lab won't go bancrupt in 2025!
By jeltsch on Fri, 11/29/2024 - 15:05The Cancer Foundation Finland has awarded us funding to continue our research into the molecular details of tumor angiogenesis.
English
The Cancer Foundation Finland has awarded us funding to continue our research into the molecular details of tumor angiogenesis.
We have just published our latest review about the role of KLK3 as an activator of VEGF-C and VEGF-D in prostate cancer. Prostate cancer is one of the most common cancers in males. It is not a question whether you will get it but only when.
Prostate-specific antigen (PSA) is well known - at least among older males - as a prostate cancer marker, but few people know its physiolo